New York, New York–(Newsfile Corp. – December 29, 2024)- BECAUSE: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Dentsply Sirona Inc. (NASDAQ: XRAY) common stock between February 28, 2022 and November 6, 2024, inclusive (the “Class Period”), of the important January 27, 2025, lead plaintiff deadline.
SO WHAT: If you purchased shares of Dentsply Sirona common stock during the Class Period, you may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Dentsply Sirona class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. at 866-767-3653 or email case@ rosenlegal.com for more information. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must file with the Court no later than January 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSENADA LAW: We encourage investors to select qualified attorneys with a track record of success in leadership roles. Often, companies issuing notices do not have comparable experience, resources or any significant recognition from their peers. Many of these firms do not actually litigate securities class actions, but are simply intermediaries who refer clients or partner with law firms that actually litigate cases. Be cautious when selecting an attorney. Rosen Law Firm represents investors throughout the world and concentrates its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest securities class action settlement against a Chinese company at that time. Rosen Law Firm Ranked No. 1 by ISS Securities Class Action (WA:) Services for several securities class action settlements in 2017. The company has ranked in the top four every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company earned more than $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of the Plaintiffs’ College. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Dentsply Sirona targeted low-income people who did not have access to good oral hygiene education, to a dentist, or dental insurance, which often meant that patients who enrolled in Byte, a direct-to-consumer (“DTC”) aligner solution, had underlying dental problems that would have made them ineligible for treatment; (2) the drive for Byte’s growth and sales commissions caused sales employees to sell to contraindicated patients; (3) as a result of the above, Byte’s patient onboarding workflow did not provide adequate assurance that contraindicated patients were not entered into treatment; (4) before and during the Class Period, reports of injuries to Byte patients were rife; (5) Dentsply Sirona knew that its Byte aligners were causing serious injuries to patients for years, but did little to investigate those injuries or notify the US Food and Drug Administration (“FDA”); (6) Dentsply Sirona did not have systems in place to notify the FDA of these injuries, which Dentsply Sirona must do within 30 days of becoming aware of the problem; (7) the FDA had received a sharp increase in reports of serious injuries to Byte patients; (8) as a result of the foregoing, Dentsply Sirona materially overstated the value of Byte’s goodwill; and (9) as a result of the foregoing, defendants’ positive statements about Dentsply Sirona’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details hit the market, the lawsuit claims investors suffered damages.
To join the Dentsply Sirona class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=31762 or call Phillip Kim, Esq. Toll-free at 866-767-3653 or email case@rosenlegal.com for information about the class action lawsuit.
No classes have been certified. Until a class is certified, you will not be represented by an attorney unless you hire one. You can select the lawyer of your choice. You can also remain an absent party member and do nothing at this time. An investor’s ability to participate in any potential future recovery is not dependent on serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https:/ /www.facebook.com/rosenlawfirm/.
Lawyer advertising. Previous results do not guarantee a similar result.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235173